An Open-label Study of EZYPRO® in Atrial Fibrillation Detection on ESUS Patients

NCT05089435 · clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
500
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sigknow Biomedical Co., Ltd.